Your browser is no longer supported. Please, upgrade your browser.
Settings
BHC Bausch Health Companies Inc. daily Stock Chart
BHC [NYSE]
Bausch Health Companies Inc.
Index- P/E- EPS (ttm)-5.35 Insider Own2.30% Shs Outstand355.30M Perf Week-1.20%
Market Cap7.16B Forward P/E4.12 EPS next Y4.38 Insider Trans122.33% Shs Float352.83M Perf Month5.25%
Income-1888.00M PEG- EPS next Q0.98 Inst Own66.80% Short Float5.40% Perf Quarter7.38%
Sales8.60B P/S0.83 EPS this Y57.00% Inst Trans17.30% Short Ratio3.82 Perf Half Y-35.88%
Book/sh1.33 P/B13.57 EPS next Y18.92% ROA-6.30% Target Price26.50 Perf Year-20.66%
Cash/sh2.26 P/C7.99 EPS next 5Y2.00% ROE-172.50% 52W Range11.15 - 31.97 Perf YTD-39.67%
Dividend- P/FCF7.88 EPS past 5Y-31.70% ROI-0.70% 52W High-43.54% Beta1.23
Dividend %- Quick Ratio0.90 Sales past 5Y0.90% Gross Margin72.90% 52W Low61.88% ATR1.01
Employees21700 Current Ratio1.10 Sales Q/Q-22.70% Oper. Margin-6.70% RSI (14)47.14 Volatility7.19% 4.42%
OptionableYes Debt/Eq51.39 EPS Q/Q-88.90% Profit Margin-23.80% Rel Volume1.99 Prev Close20.13
ShortableYes LT Debt/Eq51.39 EarningsAug 06 BMO Payout- Avg Volume4.99M Price18.05
Recom2.20 SMA20-0.99% SMA50-2.73% SMA200-18.60% Volume9,919,704 Change-10.33%
Jun-17-20Reiterated H.C. Wainwright Buy $50 → $64
Apr-24-20Initiated Citigroup Buy $30
Apr-02-20Downgrade Morgan Stanley Overweight → Equal-Weight
Jan-29-20Downgrade Wolfe Research Outperform → Peer Perform
Jan-22-20Upgrade Wells Fargo Underweight → Equal Weight $32
Dec-12-19Upgrade JP Morgan Neutral → Overweight $32 → $38
Dec-02-19Initiated Goldman Neutral
Oct-25-19Initiated Cowen Outperform $35
Sep-12-19Initiated Guggenheim Buy
Aug-15-19Upgrade TD Securities Hold → Buy
Jul-19-19Initiated Wolfe Research Outperform
Jun-11-19Resumed Barclays Overweight $28
May-13-19Upgrade JP Morgan Underweight → Neutral
Mar-20-19Initiated SunTrust Buy $30
Jan-02-19Upgrade Piper Jaffray Neutral → Overweight
Nov-05-18Upgrade Morgan Stanley Equal-Weight → Overweight
Sep-13-18Upgrade Piper Jaffray Underweight → Neutral
Aug-07-20 01:35PM  
10:48AM  
Aug-06-20 11:03AM  
10:33AM  
09:59AM  
09:57AM  
09:55AM  
09:05AM  
07:28AM  
07:12AM  
06:59AM  
06:59AM  
Aug-05-20 10:45AM  
07:00AM  
Jul-31-20 05:30PM  
04:51PM  
04:43PM  
Jul-30-20 12:33PM  
Jul-28-20 07:00AM  
Jul-23-20 07:00AM  
07:00AM  
Jul-14-20 10:03AM  
Jul-09-20 09:23PM  
Jun-29-20 06:37PM  
07:00AM  
Jun-25-20 06:17PM  
Jun-23-20 07:00AM  
Jun-17-20 04:15PM  
Jun-16-20 07:00AM  
Jun-15-20 07:00AM  
Jun-11-20 07:00AM  
Jun-06-20 11:31AM  
Jun-04-20 07:00AM  
07:00AM  
Jun-03-20 03:23AM  
12:43AM  
May-31-20 08:00AM  
May-27-20 07:00AM  
May-22-20 07:00PM  
06:46PM  
May-21-20 07:00AM  
07:00AM  
May-18-20 05:27PM  
May-17-20 10:25AM  
May-11-20 04:20PM  
04:20PM  
07:19AM  
07:08AM  
07:08AM  
May-09-20 01:30PM  
May-08-20 06:43PM  
11:05AM  
10:26AM  
May-07-20 03:17PM  
08:45AM  
07:54AM  
06:59AM  
May-06-20 08:49AM  
07:00AM  
07:00AM  
Apr-30-20 12:34PM  
07:44AM  
07:00AM  
06:45AM  
Apr-29-20 04:50PM  
04:50PM  
07:00AM  
Apr-28-20 07:00AM  
Apr-23-20 07:00AM  
07:00AM  
Apr-14-20 09:55AM  
08:00AM  
08:00AM  
Apr-13-20 07:00AM  
Apr-02-20 04:30PM  
Mar-31-20 07:00AM  
07:00AM  
Mar-30-20 08:08AM  
Mar-24-20 12:32PM  
Mar-20-20 11:30AM  
Mar-19-20 02:11PM  
Mar-14-20 08:36AM  
Mar-13-20 07:10AM  
07:00AM  
Mar-06-20 09:24PM  
Mar-02-20 06:00PM  
06:00PM  
Feb-22-20 07:25AM  
Feb-19-20 04:40PM  
04:40PM  
04:31PM  
04:22PM  
12:11PM  
08:25AM  
07:48AM  
07:16AM  
06:59AM  
Feb-18-20 02:50PM  
09:04AM  
07:00AM  
Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through four segments: Bausch + Lomb/International, Salix, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb/International segment offers products with a focus on the vision care, surgical, and consumer and ophthalmology Rx products in the United States; and Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Salix segment provides gastroenterology products in the United States. The Ortho Dermatologics segment offers dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment provides pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ValueAct Holdings, L.P.DirectorJun 05Buy19.24948,35318,246,31217,931,594Jun 09 08:24 PM
ValueAct Holdings, L.P.DirectorJun 05Sale19.24948,35318,246,3120Jun 09 08:24 PM
Paulson JohnDirectorMay 14Buy15.871,628,92025,857,83725,839,035May 14 06:25 PM
Paulson JohnDirectorMay 13Buy16.521,330,04421,972,61724,210,115May 14 06:25 PM
Paulson JohnDirectorMay 12Buy17.352,041,03635,421,08222,880,071May 14 06:25 PM
Ross Thomas W. Sr.DirectorMar 12Buy15.542,50038,83879,242Mar 16 04:24 PM
ACKERMANN CHRISTINAEVP AND GENERAL COUNSELMar 10Buy18.254,39080,10691,635Mar 11 08:52 PM
VON ESCHENBACH ANDREW C.DirectorMar 10Buy18.181,10019,99618,565Mar 11 08:50 PM
DE SCHUTTER RICHARD UDirectorMar 10Buy18.263,80069,37713,800Mar 11 08:47 PM
DE SCHUTTER RICHARD UDirectorMar 03Buy23.085,000115,415279,250Mar 11 08:47 PM